According to Spectrum Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $25.72 M. In 2022 the company made a revenue of $10.11 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $25.72 M | 154.39% |
2022 | $10.11 M | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | -100% |
2018 | $0.10 B | -14.83% |
2017 | $0.12 B | -12.34% |
2016 | $0.14 B | -9.91% |
2015 | $0.16 B | -12.99% |
2014 | $0.18 B | 19.87% |
2013 | $0.15 B | -21.55% |
2012 | $0.19 B | 2.95% |
2011 | $0.19 B | 160.36% |
2010 | $74.11 M | 94.91% |
2009 | $38.02 M | |
2007 | $7.67 M | |
2002 | $2.37 M | 5667.83% |
2001 | $0.04 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 361,445.34% | ๐บ๐ธ USA |
Novartis NVS | $51.01 B | 198,166.55% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 227,258.23% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | 155,790.24% | ๐บ๐ธ USA |
Biogen BIIB | $9.83 B | 38,127.68% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.00 B | 174,823.24% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 147,006.56% | ๐ฌ๐ง UK |
Seagen
SGEN | $2.30 B | 8,840.69% | ๐บ๐ธ USA |
Curis CRIS | $10.02 M | -61.04% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 61,488.09% | ๐ฎ๐ฑ Israel |